Core Scientific (CORZ) Q3 2026 Earnings Call Transcript
Core Scientific reported Q3 2026 earnings, highlighting a 60% sequential increase in GAAP colocation revenue and Adjusted EBITDA reaching over $130 million. The company secured $3 billion in contracts and expects further growth as CoreWeave capacity comes online. Core Scientific addressed regulatory and financing concerns, expressing confidence in their execution and community relationships.
How this was made
The 30-second read
Why it matters
The earnings beat and capital raise suggest strong operational execution, likely prompting a positive stock reaction.
Market read
Core Scientific's earnings and growth outlook are material for investors in AI infrastructure and related technology sectors.
What to watch
Potential financing constraints and regulatory risks in Texas and Georgia could limit future expansion.
Background
Core Scientific provided its Q3 2026 earnings call transcript, outlining revenue growth, EBITDA expansion, and ongoing data‑center projects with AMD and CoreWeave.
Ticker impact
Q3 2026 earnings call disclosed GAAP colocation revenue up ~60% sequentially and Adjusted EBITDA of $130M, up from $41M in Q2.
likely upward pressure as investors price in the earnings beat and growth outlook
The disclosed numbers represent material improvement and a large capital raise, which typically drives a positive price reaction.
Market effects
Highlights strength in AI data‑center infrastructure, supporting broader AI‑related hardware and cloud service stocks.
Positive for U.S. tech and infrastructure investors, especially in regions with new data‑center projects.
Reinforces demand for AI compute capacity worldwide, may influence global AI supply‑chain sentiment.
Counterpoint
If the market has already priced in AI demand, the earnings may be a short‑term catalyst but not sustain long‑term upside.
Key entities
- companyCore Scientific
AI data‑center infrastructure provider.
- partnerAMD
Customer with a 530 MW contract.
